Clinical Trials Logo

Clinical Trial Summary

The goal of this observational study is to assess the efficacy and safety of the probiotic Escherichia coli Nissle 1917 (EcN®, Ca.Di.Group S.p.A) in the treatment of symptomatic patients after an episode of both complicated and uncomplicated acute colonic diverticulitis. The main question it aims to answer are: - Is the studied probiotic able to significantly reduce symptoms, assessed by means of a validated and dedicated score? - Is there any difference in microbiota among the study group at baseline and a selected cohort of patients subdivided in subjects with diverticulosis and asymptomatic subjects after an episode of acute uncomplicated diverticulitis or an episode of complicated diverticulitis submitted to surgery with colonic resection without stoma? - Is there any difference in microbiota in the study group at baseline and after 3 and 6 months of treatment with the probiotic? - Is there any correlation between microbiota modification and symptoms during follow-up? - Is there any impact on fecal calprotectin values before and during probiotic therapy? - Is there any modification of evacuation before and during follow-up? - Is probiotic able to prevent recurrent episodes of acute diverticulitis during follow-up? - The safety of the probiotic will be assessed during the follow-up. The study group will be assessed at baseline and during follow-up with a dedicated clinical score and Bristol stool scale. Microbiota and fecal calprotectin values will be also assessed at baseline and during follow-up. Microbiota at baseline will be also evaluated for comparison in the three selected groups with diverticulosis and both asymptomatic and symptomatic after an episode of acute diverticulitis.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06040515
Study type Observational
Source University of Roma La Sapienza
Contact Antonio Tursi, MD, PhD
Phone +393473490583
Email antotursi@tiscali.it
Status Recruiting
Phase
Start date May 1, 2023
Completion date June 30, 2024

See also
  Status Clinical Trial Phase
Completed NCT03650543 - Effect of the CYP2C19 Polymorphism in Helicobacter Pylori Eradication Phase 4
Recruiting NCT05788861 - Invasive Group A Streptococcal Infection
Completed NCT03712748 - Online Imaginal Exposure N/A
Completed NCT01031667 - Synergistic Effect of Combination Therapy With Cilostazol and Probucol on Plaque Stabilization and Lesion Regression: Serial Intravascular Ultrasound and Virtual Histology Study(SECURE Study) Phase 4
Recruiting NCT00226408 - Standard High-Dose Alpha Interferon Versus Intermittent High-Dose Alpha Interferon Phase 3
Completed NCT05104957 - Evaluation of the Kinesiology Taping Effectiveness in the Treatment of Lumbar Spine Pain N/A
Recruiting NCT06137053 - Effect of Telitacicept on Transitional Regulatory B Cells in Patients With Systemic Lupus Erythematosus
Completed NCT01023126 - Obesity and Psychotherapy as an Alternative to Treatment N/A
Not yet recruiting NCT06413407 - Tai Chi Exercise and Receptive Music Therapy for the Elderly N/A
Recruiting NCT05340738 - AI-Based Fidelity Feedback to Enhance CBT N/A
Active, not recruiting NCT02455609 - Intrathecal Ketamine, Dexmedetomidine and Both With Bupivacaine for Postoperative Abdominal Cancer Surgery Pain Phase 2/Phase 3
Completed NCT05261503 - Investigation of the Effectiveness of Environmental Enrichment-Based Intervention in Preterm Infants N/A
Completed NCT04926311 - Efficiency of Speech and Language Intervention on Achievement of Children With Developmental Language Disorder
Recruiting NCT03721783 - Infant and Child European Cryoablation Project ICECaP
Recruiting NCT03283839 - Consequences of Temporomandibular Disorder on Balance Control N/A
Recruiting NCT05901558 - Strategies for Toddler ASD With Remote-therapy (STAR) Model for ASD N/A
Completed NCT03177863 - Expectancy as Alternative to Treatment for Cervical Intraepithelial Neoplasia Grade 2 Among Women 25 - 30 Years of Age N/A
Recruiting NCT06146972 - Efficacy Study of Iguratimod Combined With Tofacitab in Patients With RF Positive/Negative Rheumatoid Arthritis Phase 4
Recruiting NCT03161249 - Psychoeducative Treatment of FEP With Mobile Training N/A
Recruiting NCT04490317 - CARbon monoxidE intoxiCatiOn in Korea: Prospective Cohort (CARE CO Cohort)